Aiumtrakul N, Phichedwanichskul K, Saravutthikul S, Ottasat K, Visuthitepkul K, Jaruthiti T
BMC Nephrol. 2021; 22(1):18.
PMID: 33419413
PMC: 7791992.
DOI: 10.1186/s12882-020-02215-8.
Sharma D, Asirvatham A, Singh P
Indian J Endocrinol Metab. 2017; 21(4):618-629.
PMID: 28670548
PMC: 5477452.
DOI: 10.4103/ijem.IJEM_442_16.
Baba T, Ishizaki T
Drugs. 2017; 43(4):464-489.
PMID: 28421556
DOI: 10.2165/00003495-199243040-00004.
Joven M, Anderson R
Curr Diab Rep. 2015; 15(7):44.
PMID: 25990743
DOI: 10.1007/s11892-015-0613-6.
Xia F, Liu G, Shi Y, Zhang Y
Int J Clin Exp Med. 2015; 8(1):1-9.
PMID: 25784968
PMC: 4358423.
Incidence of microalbuminuria in tobacco chewers.
Shah H
Indian J Clin Biochem. 2012; 20(2):189-91.
PMID: 23105559
PMC: 3453826.
DOI: 10.1007/BF02867426.
Metabolic acidosis-induced insulin resistance and cardiovascular risk.
Souto G, Donapetry C, Calvino J, Adeva M
Metab Syndr Relat Disord. 2011; 9(4):247-53.
PMID: 21352078
PMC: 3155690.
DOI: 10.1089/met.2010.0108.
[Diabetic nephropathy and cardiovascular risk].
Avila Lachica L, Gomez Garcia M
Aten Primaria. 2009; 42(3):173-5.
PMID: 19647899
PMC: 7022067.
DOI: 10.1016/j.aprim.2009.06.004.
Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?.
Bakker S, Gansevoort R, de Zeeuw D
Curr Hypertens Rep. 2009; 11(2):111-7.
PMID: 19278600
DOI: 10.1007/s11906-009-0021-x.
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.
Atthobari J, Gansevoort R, Visser S, de Jong P, de Jong-van den Berg L
Br J Clin Pharmacol. 2007; 63(2):224-31.
PMID: 17274790
PMC: 2000576.
DOI: 10.1111/j.1365-2125.2006.02747.x.
Impact of blood pressure vs. glycemic factors on target organ damage in patients with type 2 diabetes mellitus.
Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Shimada K, Kario K
J Clin Hypertens (Greenwich). 2006; 8(6):404-10.
PMID: 16760678
PMC: 8109584.
DOI: 10.1111/j.1524-6175.2006.04739.x.
Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.
Cohen M, Ziyadeh F, Chen S
J Lab Clin Med. 2006; 147(5):211-9.
PMID: 16697768
PMC: 1800931.
DOI: 10.1016/j.lab.2005.12.006.
Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?.
Poulou A, Goumas K, Dandakis D, Tyrmpas I, Panagiotaki M, Georgouli A
World J Gastroenterol. 2006; 12(5):739-46.
PMID: 16521187
PMC: 4066124.
DOI: 10.3748/wjg.v12.i5.739.
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?.
Bakker S, Gansevoort R, Stuveling E, Gans R, de Zeeuw D
Curr Hypertens Rep. 2005; 7(5):379-84.
PMID: 16157083
DOI: 10.1007/s11906-005-0075-3.
Microalbuminuria: definition, detection, and clinical significance.
Toto R
J Clin Hypertens (Greenwich). 2004; 6(11 Suppl 3):2-7.
PMID: 15538104
PMC: 8109505.
DOI: 10.1111/j.1524-6175.2004.4064.x.
An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes.
Stephens J, Hurel S, Acharya J, Humphries S
Cardiovasc Diabetol. 2004; 3:2.
PMID: 14992698
PMC: 375540.
DOI: 10.1186/1475-2840-3-2.
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Marre M, Lievre M, Chatellier G, Mann J, Passa P, Menard J
BMJ. 2004; 328(7438):495.
PMID: 14960504
PMC: 351842.
DOI: 10.1136/bmj.37970.629537.0D.
Cost-effective strategies in the prevention of diabetic nephropathy.
Rippin J, Barnett A, Bain S
Pharmacoeconomics. 2004; 22(1):9-28.
PMID: 14720079
DOI: 10.2165/00019053-200422010-00002.
Microalbuminuria and diabetic cardiovascular disease.
MacIsaac R, Cooper M
Curr Atheroscler Rep. 2003; 5(5):350-7.
PMID: 12911844
DOI: 10.1007/s11883-003-0005-2.
The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm.
Adler S, Nast C
Curr Diab Rep. 2003; 1(3):241-4.
PMID: 12643205
DOI: 10.1007/s11892-001-0041-7.